4//SEC Filing
Laliberte Kevin 4
Accession 0001209191-19-002826
CIK 0001685071other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 5:01 PM ET
Size
7.7 KB
Accession
0001209191-19-002826
Insider Transaction Report
Form 4
Laliberte Kevin
Sr. VP, Product Development
Transactions
- Award
Common Stock
2019-01-04+7,937→ 14,137 total - Award
Employee Stock Option (right to buy)
2019-01-04+50,000→ 50,000 totalExercise: $8.82Exp: 2029-01-03→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award that vests 50% on each of June 30, 2019 and 25% on each of September 30, 2019 and December 31, 2019.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]25% of the total shares subject to the option shall vest on December 31, 2019, and 1/48th of total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service with the Issuer as of each such date. The option allows for early exercise, subject to the Issuer's repurchase option, with respect to any unvested shares of Common Stock.
Documents
Issuer
Dova Pharmaceuticals Inc.
CIK 0001685071
Entity typeother
Related Parties
1- filerCIK 0001709417
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 5:01 PM ET
- Size
- 7.7 KB